World Biotechnology

worldbiotechnology.com

World Biotechnology is an early stage synthetic biology company that will lower the cost of production in chemicals, fuels, pharmaceuticals, nutraceuticals, and agribusiness, and reduce the carbon footprint along the way. WB has developed a proprietary method to enable microorganisms to be significantly more efficient in the production of products such as pharmaceuticals, glucose, oils, and biofuels.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

BIO-TECHNE AND KANTARO BIOSCIENCES ANNOUNCED THE LAUNCH OF THE COVID-SEROINDEX, A KANTARO QUANTITATIVE SARS-COV-2 IGG ANTIBODY RUO KIT

Bio-Techne | August 04, 2020

news image

Bio-Techne Corporation (NASDAQ:TECH) and the Mount Sinai Health System in New York, through its commercial affiliate Kantaro Biosciences LLC (Kantaro), today announced the anticipated launch of the COVID-SeroIndex, a Kantaro Quantitative SARS-CoV-2 IgG Antibody RUO kit. Bio-Techne and Kantaro will leverage a joint commercialization and distribution team to support rapid distribution of the assay to the vaccine development community. The COVID-SeroIndex test kit is expected to be available ...

Read More

Medical

NAVIGATE BIOPHARMA SERVICES, INC. LAUNCHES NEW MULTIPLEX DIGITAL PCR ASSAY FOR COMPREHENSIVE QUANTIFICATION OF UP TO 5 DIFFERENT CAR-T TRANSGENES

PRNewswire | June 02, 2023

news image

During this year's AAPS National biotechnology conference, Navigate BioPharma Services, Inc., a Novartis subsidiary and a leading provider of innovative biomarker solutions for drug development, announced the launch of its new multiplex digital PCR assays for comprehensive quantification of multiple chimeric antigen receptor (CAR) T cells, a type of cancer immunotherapy that involves genetically modifying T cells to recognize and destroy certain cancers. These assays are based on the Q...

Read More

RESEARCH SOLUTIONS ANNOUNCES PARTNERSHIP WITH BIO BUSINESS SOLUTIONS TO BRING ONE-CLICK SCIENTIFIC LITERATURE ACCESS TO THE BIOTECH INDUSTRY

Research Solutions | October 12, 2020

news image

Research Solutions/Reprints Desk (NASDAQ: RSSS), a pioneer in providing cloud-based workflow solutions for R&D driven organizations, today announced that it has partnered with BIO Business Solutions to help life sciences companies save time and money on scholarly literature access via its award-winning Article Galaxy research platform. Operated by the Biotechnology Innovation Organization (BIO), BIO Business Solutions is the industry's largest cost savings purchasing program. More than 4...

Read More

BIOCLEAN INNOVATIONS AND REP-L® ANTIMICROBIALS PARTNERS TO LAUNCH A POWERFUL NON-TOXIC BIO-BASED ANTIMICROBIAL PRODUCT LINE

Bioclean Innovations | October 19, 2020

news image

Bioclean Innovations Inc, a Biotech startup focused on innovative antimicrobial solutions to combat disease outbreaks has partnered with rep-L® Antimicrobials, to launch a powerful but non-toxic bio-based antimicrobial product line. Our rep-L-based disinfectants are designed to create a new methodology for addressing the infection control challenges facing the education and long-term health care sectors today. The SARS-CoV-2 virus responsible for the COVID-19 pandemic is one of an increasing...

Read More
news image

BIO-TECHNE AND KANTARO BIOSCIENCES ANNOUNCED THE LAUNCH OF THE COVID-SEROINDEX, A KANTARO QUANTITATIVE SARS-COV-2 IGG ANTIBODY RUO KIT

Bio-Techne | August 04, 2020

Bio-Techne Corporation (NASDAQ:TECH) and the Mount Sinai Health System in New York, through its commercial affiliate Kantaro Biosciences LLC (Kantaro), today announced the anticipated launch of the COVID-SeroIndex, a Kantaro Quantitative SARS-CoV-2 IgG Antibody RUO kit. Bio-Techne and Kantaro will leverage a joint commercialization and distribution team to support rapid distribution of the assay to the vaccine development community. The COVID-SeroIndex test kit is expected to be available ...

Read More
news image

Medical

NAVIGATE BIOPHARMA SERVICES, INC. LAUNCHES NEW MULTIPLEX DIGITAL PCR ASSAY FOR COMPREHENSIVE QUANTIFICATION OF UP TO 5 DIFFERENT CAR-T TRANSGENES

PRNewswire | June 02, 2023

During this year's AAPS National biotechnology conference, Navigate BioPharma Services, Inc., a Novartis subsidiary and a leading provider of innovative biomarker solutions for drug development, announced the launch of its new multiplex digital PCR assays for comprehensive quantification of multiple chimeric antigen receptor (CAR) T cells, a type of cancer immunotherapy that involves genetically modifying T cells to recognize and destroy certain cancers. These assays are based on the Q...

Read More
news image

RESEARCH SOLUTIONS ANNOUNCES PARTNERSHIP WITH BIO BUSINESS SOLUTIONS TO BRING ONE-CLICK SCIENTIFIC LITERATURE ACCESS TO THE BIOTECH INDUSTRY

Research Solutions | October 12, 2020

Research Solutions/Reprints Desk (NASDAQ: RSSS), a pioneer in providing cloud-based workflow solutions for R&D driven organizations, today announced that it has partnered with BIO Business Solutions to help life sciences companies save time and money on scholarly literature access via its award-winning Article Galaxy research platform. Operated by the Biotechnology Innovation Organization (BIO), BIO Business Solutions is the industry's largest cost savings purchasing program. More than 4...

Read More
news image

BIOCLEAN INNOVATIONS AND REP-L® ANTIMICROBIALS PARTNERS TO LAUNCH A POWERFUL NON-TOXIC BIO-BASED ANTIMICROBIAL PRODUCT LINE

Bioclean Innovations | October 19, 2020

Bioclean Innovations Inc, a Biotech startup focused on innovative antimicrobial solutions to combat disease outbreaks has partnered with rep-L® Antimicrobials, to launch a powerful but non-toxic bio-based antimicrobial product line. Our rep-L-based disinfectants are designed to create a new methodology for addressing the infection control challenges facing the education and long-term health care sectors today. The SARS-CoV-2 virus responsible for the COVID-19 pandemic is one of an increasing...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us